Omalizumab safety in pregnancy

J Allergy Clin Immunol. 2020 Feb;145(2):481-483. doi: 10.1016/j.jaci.2019.11.018. Epub 2019 Nov 26.

Authors

Francesca Levi-Schaffer¹, David Mankuta²

Affiliations

¹ Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: francescal@ekmd.huji.ac.il.
² Department of Obstetrics and Gynecology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

PMID: 31778706
DOI: 10.1016/j.jaci.2019.11.018

No abstract available

Keywords: Omalizumab; drug safety; fetal malformations; placental transfer; pregnancy; preterm delivery; thrombocytopenia.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cohort Studies
Female
Humans
Omalizumab
Pregnancy
Pregnancy Outcome*
Premature Birth*
Registries

Substances

Omalizumab